These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15139330)

  • 1. India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but critics fear Indian patients will become guinea pigs.
    Sharma DC
    Lancet; 2004 May; 363(9420):1528-9. PubMed ID: 15139330
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA under pressure to relax drug rules.
    Ledford H
    Nature; 2012 Dec; 492(7427):19. PubMed ID: 23222585
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the European clinical trials directive really improve clinical trial approval time?
    Lambers Heerspink HJ; Dobre D; Hillege HL; Grobbee DE; de Zeeuw D
    Br J Clin Pharmacol; 2008 Oct; 66(4):546-50. PubMed ID: 18662290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration, partner in drug development.
    Yates JW
    CA Cancer J Clin; 2006; 56(6):321-2. PubMed ID: 17135690
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian Supreme Court halts approval of new clinical trials until regulatory framework is set up.
    Bagcchi S
    BMJ; 2013 Oct; 347():f5996. PubMed ID: 24097130
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug companies cut costs with foreign clinical trials.
    Rai S
    N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
    Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
    BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Legal liability in clinical trials from the legal-pharmaceutical viewpoint].
    Amon F
    Z Arztl Fortbild (Jena); 1995 Nov; 89(6):638-41. PubMed ID: 8588437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
    Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Companies' use of web to recruit patients for studies brings opportunities, risks.
    Kuehn BM
    JAMA; 2008 Jun; 299(23):2733-4. PubMed ID: 18559993
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug companies should release data from all trials of licensed drugs, say MPs.
    Hawkes N
    BMJ; 2013 Jan; 346():f321. PubMed ID: 23325880
    [No Abstract]   [Full Text] [Related]  

  • 12. Patients, physicians, and clinical trials: the other side of the coins.
    Abramson SB; Flexner C; Snyderman R; Dieterich DT; Korn D; Temple R; Sherwood L; Goldblatt D
    J Investig Med; 1999 Sep; 47(8):343-57. PubMed ID: 10510587
    [No Abstract]   [Full Text] [Related]  

  • 13. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 14. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics committees in India: A study to assess the implementation of registration requirements as per New Drug and Clinical Trial Rules and the scale of standardization.
    Krishnan M; Sherief HS
    Natl Med J India; 2023; 36(2):109-111. PubMed ID: 38692601
    [No Abstract]   [Full Text] [Related]  

  • 16. External influences on protocol design.
    Spilker B
    Epilepsy Res Suppl; 1993; 10():115-24. PubMed ID: 8251087
    [No Abstract]   [Full Text] [Related]  

  • 17. New European clinical trial regulations are "unacceptable" to industry.
    Davidson S
    Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
    [No Abstract]   [Full Text] [Related]  

  • 18. Earlier drug tests on people could be unsafe, critics warn.
    Wadman M
    Nat Med; 2006 Feb; 12(2):153. PubMed ID: 16462779
    [No Abstract]   [Full Text] [Related]  

  • 19. New Drugs and Clinical Trials Rules, 2019: The market trumps ethics and participant rights.
    Jesani A; Srinivasan S
    Indian J Med Ethics; 2019; 4(2):89-91. PubMed ID: 31271361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The e-recruitment of participants for clinical trials.
    Ehrenberger HE
    IRB; 2003; 25(4):16-7. PubMed ID: 14649250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.